Skip to main content
FBIO logo
FBIO
(NASDAQ)
Fortress Biotech, Inc.
$2.60-- (--)
Loading... - Market loading

Fortress Biotech (FBIO) Stock Price & Financial Analysis

Fortress Biotech Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.41 - $2.60
52-Week High$4.53
52-Week Low$1.33
Open$2.42
Volume515.20K
Average Volume (3M)515.20K
Market Cap86.06M
Shares Outstanding33.10M
P/E Ratio (TTM)20.51
Price to Sales (P/S)1.31
Price to Book (P/B)1.46
EV/EBITDA-1.26
Revenue (TTM)62.30M
Net Income (TTM)3.99M
EPS (TTM)$0.12
Profit Margin6.40%
Operating Margin-149.18%
Return on Equity (ROE)7.14%
Debt to Equity0.96
50-Day MA$3.25
200-Day MA$2.86
52-Week Change60.39%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Fortress Biotech

What is the current stock price for FBIO?

As of the latest trading session, FBIO stock trades at $2.60. The 52-week range is $1.33–$4.53, with a day range of $2.41–$2.60.

What is the P/E ratio for FBIO?

Fortress Biotech's trailing P/E ratio is 20.5, meaning investors pay $20.5 for every $1 of annual earnings. Fortress Biotech operates in the Healthcare sector.

Does FBIO pay dividends?

Fortress Biotech does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for FBIO?

Based on 1 analyst, the consensus for FBIO is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of FBIO?

Fortress Biotech's market capitalization is $86.1M, classifying it as a micro-cap company. Fortress Biotech operates in the Healthcare sector within the Biotechnology industry.